IBD
Glycocaging: A Smart Chemistry Platform for Safer, Smarter IBD Treatments
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-03Jul 14, 2025
Recruitment
Bringing Clinical Trial Enrollment to the Point of Diagnosis
Tim Rich; Matt Schwartz
PPD clinical research business of Thermo Fisher Scientific
PAO-04-25-CL-01Apr 28, 2025
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Liz Boazak, Ph.D.
Altis Biosystems
PAO-03-21-CL-01Mar 11, 2021
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Bailey Zwarycz, Ph.D
Altis Biosystems
PAO-02-21-CL-01Feb 4, 2021
Launch
Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering
Mylan
PR-M01-19-NI-001Jan 2, 2019
Gastroenterology
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid® SoluTab Delayed-Release Orally Disintegrating Tablets
Mylan
PR-M12-18-NI-022Dec 7, 2018
Stem-Cell
Stem Cell Research May Lead to Treatments for Gastrointestinal Diseases
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-019Sep 25, 2018
FDA Approval
Alteogen Gets FDA Approval for Orphan Drug Designation with an Antibody-Drug Conjugate for Gastric Cancer
Alteogen
PR-M08-18-NI-052Aug 14, 2018
Innovation
Joint Program Explores Devices to Treat Gastrointestinal Disease
Emilie Branch
Pharma's Almanac
PAO-M08-17-NI-004Aug 1, 2017